Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MetaFines
company
About
MetaFines is researching and developing anti-cancer drugs using cancer metabolism.
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ₩20B
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Oct 8, 2018
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
₩20B
MetaFines has raised a total of
₩20B
in funding over 2 rounds. Their latest funding was raised on
Apr 28, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 28, 2022 | Series B | ₩20B | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
MetaFines is funded by 3 investors.
Korea Investment Securities
and SNS-Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
